Summary
- Updated December 10, 2024
To whom does this guideline apply…
-
ANZCOR Scientific Statements
-
Algorithms and Flowcharts
-
Guideline Development
-
Basic Life Support
-
First Aid Management of Injuries
-
First Aid for Medical Conditions
-
First Aid for the Environment
-
First Aid for Bites, Stings and Poisoning
-
Education and Implementation
-
Adult Advanced Life Support
-
Paediatric Advanced Life Support
-
Newborn Resuscitation
-
Acute Coronary Syndromes
Symptomatic Therapy
- Updated December 10, 2024
There are several therapies in patients…
Aspirin administration
- Updated December 10, 2024
The early administration of aspirin…
Antiplatelet Agents
- Updated December 10, 2024
Ticagrelor is a pyrimidine derivative…
Anticoagulants in Non-ST Elevation Acute Coronary Syndrome (NSTEACS)
- Updated December 10, 2024
In people presenting with NSTEACS…
Anticoagulants in STEMI treated with Fibrinolysis
- Updated December 10, 2024
In patients with STEMI in the…
Anticoagulants in STEMI treated with PCI
- Updated December 10, 2024
Anticoagulation is recommended in all…
Glycoprotein IIBIIIA inhibitors
- Updated December 10, 2024
Routine use of glycoprotein (GP…
Optimal Medical Therapy for Primary and Secondary Prevention
- Updated December 10, 2024
There are several additional medical…
Antiarrhythmics
- Updated December 10, 2024
There is no high-level evidence to…
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155